Biotech company Moderna is scheduled to begin human trials next month for two mRNA-based HIV vaccines, according to the National Institutes of Health’s clinical trial registry. The study, in the Phase I stage, would measure the safety of the vaccine and collect information on whether the potential vaccine has an impact on HIV. The research … Continue reading HIV vaccine using mRNA technology being developed by Moderna